NCT06891573

Brief Summary

The goal of this feasibility randomized controlled trial is to investigate the applicability of software that aims to improve symptoms of frailty by implementing customized interventions such as physical exercise and cognitive training implemented through a mobile app for 16 weeks for patients diagnosed with frailty or prefrailty. The primary outcomes are adherence, retention rates, and recruitment rates. Participants will participate in customized interventions including physical exercise, cognitive training, nutritional guidance, and management of disease related to frailty for 16 weeks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

February 26, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

March 24, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

November 20, 2025

Status Verified

November 1, 2025

Enrollment Period

10 months

First QC Date

February 25, 2025

Last Update Submit

November 17, 2025

Conditions

Keywords

frailtyinterventionmultidomaindigital

Outcome Measures

Primary Outcomes (3)

  • retention rate

    retention rate ≥ 70%

    From enrollment to the end of intervention at 16 weeks

  • Adherence to the protocol

    Adherence to the protocol ≥ 70%

    From enrollment to the end of intervention at 16 weeks

  • recruitment rate

    recruitment rate ≥ 50%.

    From enrollment to the end of intervention at 16 weeks

Secondary Outcomes (29)

  • Change from Baseline in Korean Frailty Index for Primary Care at 16 weeks

    From baseline to the end of intervention at 16 weeks

  • Change from Baseline in Modified Fried frailty phenotype score at 16 weeks

    From baseline to the end of intervention at 16 weeks

  • Change from Baseline in Lubben Social Network Scale at 16 weeks

    From baseline to the end of intervention at 16 weeks

  • Change from Baseline in 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale at 16 weeks

    From baseline to the end of intervention at 16 weeks

  • Change from Baseline in Korean Mini-Mental State Examination-2 at 16 weeks

    From enrollment to the end of intervention at 16 weeks

  • +24 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants will receive interventions including exercise, cognitive training, nutrition education, and management of diseases related to frailty via the app for one hour per day, five days a week for 16 weeks.

Behavioral: Lifestyle Management

Control

NO INTERVENTION

Participants in the control group will receive standard treatment related to frailty during the study period and be provided with guidelines on 'Lifestyle habits for treating frailty or prefrailty'.

Interventions

For 16 weeks, participants will receive exercise, cognitive training, nutrition education, and disease education through a smartphone app, and the content and intensity of the intervention will be adjusted every four weeks through an assessment of frailty symptoms through the app.

Intervention group

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • Residing in the community
  • Total score of Modified Fried frailty phenotype score ≥ 1 point
  • Korean Mini-Mental State Examination-2 z-score ≥ -1.5
  • Can read and write
  • Being able to use the a mobile app through education or having someone help a participant use the mobile app
  • Having a reliable informant who could provide investigators with the requested information.
  • written informed consent

You may not qualify if:

  • Major psychiatric illness such as major depressive disorders
  • Dementia
  • Other neurodegenerative disease (e.g., Parkinson's disease)
  • Malignancy within five years
  • Cardiac stent or revascularization within one year
  • Serious or unstable symptomatic cardiovascular disease
  • Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease
  • Severe loss of vision, hearing, or communicative disability
  • Significant laboratory abnormality that may result in cognitive impairment
  • Any conditions preventing cooperation as judged by the study physician
  • Unable to participate in exercise program safely
  • Coincident participation in any other intervention trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Inha University Hospital

Incheon, 22332, South Korea

RECRUITING

Ewha Womans University Seoul hospital

Seoul, South Korea

NOT YET RECRUITING

Ajou University Hospital

Suwon, South Korea

NOT YET RECRUITING

Related Publications (1)

  • Jung S, Kang HJ, Moon SY, Choi M, Jung J, Kim HR, Jung S, Jeong JH, Choi SH, Park YK. South Korean study to prevent the progression of frailty and aging-related diseases using a digital multidomain intervention (SUPERAGING): Protocol of a feasibility pilot study. Digit Health. 2026 Jan 6;12:20552076251410995. doi: 10.1177/20552076251410995. eCollection 2026 Jan-Dec.

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Seong Hye Choi, MD, PhD

    Inha University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seong Hye Choi, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 24, 2025

Study Start

February 26, 2025

Primary Completion

December 20, 2025

Study Completion

January 15, 2026

Last Updated

November 20, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Individual participant data will be shared with the Global Alzheimer's Association Interactive Network.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will become in 2027 and become available for 5 years.
Access Criteria
The access criteria is an approval of steering committee.

Locations